InvestorsHub Logo
Followers 222
Posts 13853
Boards Moderated 0
Alias Born 08/12/2011

Re: None

Friday, 07/20/2018 3:27:44 PM

Friday, July 20, 2018 3:27:44 PM

Post# of 203909

Please provide proof of your following statement:

""...the only thing proven, is that the so called cream works on healthy patients."



Oh boy! If you had read that post carefully you would have known I wasn't the poster of that statement to begin with smile

But, at least, he/she was right about it!

Let me help you with the source here smile

Gotta get back to work. Good luck to all $OWCP shareholders!


"OWC Pharmaceutical Research Corp. (“OWC”) through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., announces the successful completion of the first part of its Phase I, placebo controlled, maximal dose study (the “Psoriasis Study”) to determine the safety and tolerability of topical ointment containing medical grade cannabis (the “Topical Ointment”) in healthy volunteers. The study is being performed by Professor Aviv Barzilai, Director of the Department of Dermatology at Chaim Sheba Medical Center. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and is one of the leading integrated medical centers in the Middle East. The completed part of the study consisted of application of escalating doses of the Topical Ointment to healthy volunteers and was successfully completed with no adverse effects. After completion of the second part of this study, the company plans to initiate a phase II clinical study to demonstrate the efficacy of Topical Ointment in treating mild to moderate psoriasis and other inflammatory skin diseases.